Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to upadacitinib in a patient with atopic dermatitis and HIV.
Riquelme-Mc Loughlin C, Sánchez-Palomino S, Blanco JL. Riquelme-Mc Loughlin C, et al. Among authors: blanco jl. Int J Dermatol. 2024 Jul 19. doi: 10.1111/ijd.17399. Online ahead of print. Int J Dermatol. 2024. PMID: 39031980 No abstract available.
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study.
de Lazzari E, Nomah DK, Blanco JL, Rico N, Filella X, Egri N, Ruiz R, Marcos MA, Mosquera MDM, Alcamí J, Sánchez-Palomino S, Bruguera A, Hurtado C, Rovira C, Ambrosioni J, Chivite I, González-Cordón A, Inciarte A, Laguno M, Martínez-Rebollar M, de la Mora L, Torres B, Díaz Y, Martínez E, Mallolas J, Miro JM; Hospital Clinic HIV investigators. de Lazzari E, et al. Among authors: blanco jl. Int J Infect Dis. 2024 Dec;149:107266. doi: 10.1016/j.ijid.2024.107266. Epub 2024 Oct 18. Int J Infect Dis. 2024. PMID: 39423949 Free article.
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations.
Inciarte A, de la Mora L, Huaier-Arriazu E, Torres B, Cañizares S, Zamora E, Laguno M, Gonzalez-Cordón A, Foncillas A, Chivite I, Calvo J, Ambrosioni J, Martínez E, Blanco JL, Miro JM, Martinez-Rebollar M, Mallolas J. Inciarte A, et al. Among authors: blanco jl. Infect Dis Ther. 2024 Apr;13(4):647-658. doi: 10.1007/s40121-024-00962-x. Epub 2024 Apr 3. Infect Dis Ther. 2024. PMID: 38570445 Free PMC article.
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine.
de Lazzari E, Negredo EB, Domingo P, Tiraboschi JM, Ribera E, Abdulghani N, Alba V, Fernández-Arroyo S, Viladés C, Peraire J, Gatell JM, Blanco JL, Vidal F, Rull A, Martinez E. de Lazzari E, et al. Among authors: blanco jl. J Antimicrob Chemother. 2024 May 2;79(5):1133-1141. doi: 10.1093/jac/dkae083. J Antimicrob Chemother. 2024. PMID: 38546974 Free PMC article. Clinical Trial.
Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study.
Martí-Pastor M, García de Olalla P, Barberá MJ, Manzardo C, Ocaña I, Knobel H, Gurguí M, Humet V, Vall M, Ribera E, Villar J, Martín G, Sambeat MA, Marco A, Vives A, Alsina M, Miró JM, Caylà JA; HIV Surveillance Group. Martí-Pastor M, et al. BMC Public Health. 2015 Oct 5;15:1015. doi: 10.1186/s12889-015-2344-7. BMC Public Health. 2015. PMID: 26438040 Free PMC article.
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
Leal L, León A, Torres B, Inciarte A, Lucero C, Mallolas J, Laguno M, Martínez-Rebollar M, González-Cordón A, Manzardo C, Rojas J, Pich J, Arnaiz JA, Gatell JM, García F; RALPEP Study Group. Leal L, et al. J Antimicrob Chemother. 2016 Jul;71(7):1987-93. doi: 10.1093/jac/dkw049. Epub 2016 Mar 18. J Antimicrob Chemother. 2016. PMID: 26994089 Clinical Trial.
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
Leal L, León A, Torres B, Inciarte A, Lucero C, Mallolas J, Laguno M, Martínez-Rebollar M, González-Cordón A, Manzardo C, Rojas J, Pich J, Arnaiz JA, Gatell JM, García F; MARAVIPEP Study Group. Leal L, et al. J Antimicrob Chemother. 2016 Jul;71(7):1982-6. doi: 10.1093/jac/dkw048. Epub 2016 Mar 18. J Antimicrob Chemother. 2016. PMID: 26994091 Clinical Trial.
Sexually transmitted infections in young people and factors associated with HIV coinfection: an observational study in a large city.
Sentís A, Martin-Sanchez M, Arando M, Vall M, Barbera MJ, Ocaña I, González Cordón A, Alsina M, Martin-Ezquerra G, Knobel H, Gurguí M, Vives A, Coll J, Caylà JA, Garcia de Olalla P; STI-HIV group of Barcelona. Sentís A, et al. BMJ Open. 2019 May 5;9(5):e027245. doi: 10.1136/bmjopen-2018-027245. BMJ Open. 2019. PMID: 31061051 Free PMC article.
Photodermatitis in a patient with HIV infection.
López-Lerma I, Alsina MM, Blanco JL, Lecha M. López-Lerma I, et al. Among authors: blanco jl. J Am Acad Dermatol. 2003 Jul;49(1):159-60. doi: 10.1016/s0190-9622(03)70102-9. J Am Acad Dermatol. 2003. PMID: 12833035 No abstract available.
344 results